Loading...
SITCSection 5
U.S. imports of medicaments nes, in dosage or retail form (SITC 54293) totaled $5.6B in April 2026, traded with 59 countries.
Importers of Medicaments NES, in Dosage or Retail Form paid $288K in duties in April 2026 — an effective duty rate of 9.6% on $3.0M in dutiable value, based on actual customs collections rather than the published tariff schedule. Medicaments NES, in Dosage or Retail Form imports of $5.6B in April 2026 ran 15% above the year-to-date monthly average of $4.9B.
Last updated: April 2026 dataFinished pharmaceutical products in dosage or retail packaging that do not fit a more specific SITC heading—covering a broad sweep of formulated drugs from antihistamines to topical preparations—are captured under SITC 54293. Because this is a residual 'not elsewhere specified' category, correct classification requires ruling out all more-specific SITC headings for alkaloid-based (54232) or vitamin-based (54292) medicaments first. FDA prior notice, foreign facility registration, and drug admissibility review apply to all finished pharmaceutical imports regardless of active ingredient. For products originating in countries subject to Section 301 measures, additional duties may apply on top of the base rate. Importers should consult a licensed customs broker and confirm FDA admissibility status before arranging shipment.
AI-written summary of the official U.S. Census Bureau trade figures on this page — verify before relying on it.
The classification hierarchy requires checking whether the active ingredient is an alkaloid derivative (54232) or a vitamin/provitamin (54292) first. Only products that do not fit those or other named headings fall into the NES category 54293. Reviewing the full SITC schedule alongside the product's ingredient declaration is the standard starting point.
FDA most frequently detains finished drug imports for unregistered foreign facilities, labeling non-compliance (including unapproved drug claims), and failure to file prior notice. Products that appear to be unapproved new drugs or that lack adequate English labeling are also common detention triggers. Resolving these holds typically requires direct engagement with FDA's Division of Import Operations.
Supplier Network
Get discovered by U.S. importers searching for HS 54293 — Medicaments NES, in Dosage or Retail Form. Be the first supplier listed.
| Country | Imports | Exports | Balance |
|---|---|---|---|
| SWITZERLAND | $1.3B | $37.4M | -$1.3B |
| IRELAND | $812.7M | $73.1M | -$739.6M |
| GERMANY | $167.4M | $424.2M | +$256.8M |
| INDIA | $539.7M | $11.3M | -$528.4M |
| FRANCE | $501.2M | $23.7M | -$477.5M |
Monthly import values over time